Overview
Gurugram-based natural pain therapeutics startup Wholeleaf is in advanced talks to raise Rs 7.5 crore from institutional investors IPV and Benzai 10 Capital. This follows a successful track record of earlier capital raises, including a notable appearance on Shark Tank India.
Company Background and Traction
Founded in 2021 by Shivraj Sharma, Wholeleaf specializes in cannabinoid-based pain management solutions. The startup has built a robust product portfolio addressing chronic conditions such as migraines, arthritis, fibromyalgia, and anxiety. The company reports an ARR of Rs 18 crore and has successfully established a presence in 2,000 retail outlets, primarily in the Delhi-NCR region.
Strategic Growth Plan
The company plans to utilize the fresh capital to achieve several key milestones:
- Expand retail footprint from 2,000 to 5,000–7,000 outlets.
- Deepen market penetration across major Tier I and Tier II cities, including Mumbai, Bengaluru, and Hyderabad.
- Invest in sustainable product infrastructure and clinical validation pipelines.
Founder Takeaway
Shivraj Sharma emphasizes that success in the medical therapeutics space requires balancing rapid growth with strict regulatory discipline and high medical trust. Founders in highly regulated health sectors should prioritize third-party validations and clinical rigor to secure institutional backing.